Stock Watch: After The Pandemic, Different Vaccines To The Rescue
Pfizer’s Third-Quarter Results Included Belated Acceptances And Echoes For GSK
From the unfavorable comparisons brought about by lower pandemic-related product sales, vaccines for other diseases bring hopes for longer-term success.
